Annual Report to the Nation on the Status of Cancer showed cancer death rates dropped from 1993-2002
On Oct. 5, 2005, the National Cancer Institute’s Annual Report to the Nation on the Status of Cancer,…
On Oct. 5, 2005, the National Cancer Institute’s Annual Report to the Nation on the Status of Cancer,…
On Sept. 28, 2005, the National Cancer Institute and the National Institute of Neurological Disorders and Stroke (NINDS)…
On Sept. 26, 2005, San Diego business leader and philanthropist John J. Moores contributed $4 million to The…
On Sept. 22, 2005, the Siteman Cancer Center opened a new center at Barnes-Jewish St. Peters Hospital. The…
On Sept. 16, 2005, preliminary results from a large, clinical trial of digital vs. film mammography showed no…
On Sept. 12, 2005, David H. Murdock announced a $1.5 billion scientific and economic revitalization project called the…
On Sept. 6, 2005, the MMRV vaccine was licensed in the United States and may be used instead…
On Aug. 31, 2005, the inactivated, injectable influenza vaccine (Fluarix) by GlaxoSmithKline (GSK) was licensed. The vaccine was…
On Aug. 29, 2005, the U.S. Centers for Disease Control and Prevention (CDC) responded to the crises presented…
On Aug. 11, 2005, the Food and Drug Administration (FDA) approved an application of a pediatric/adolescent formulation of…
On Aug. 8, 2005, the Energy Policy Act of 2005 (EPAct) is the first major energy law enacted…
On Jul. 16, 2005, Virginia Mason Medical Center, now know as the Benaroya Research Institute at Virginia Mason,…
On Jul. 13, 2005, The Life Sciences Discovery Fund Authority (LSDF) was established and a total of $350…
On Jul. 12, 2005, Corixa Corp., based on First Hill in Seattle, was acquired by Glaxosmithkline (GSK) for…
On Jun. 29, 2005, the Patient Navigator Outreach and Chronic Disease Prevention Act of 2005 (P.L. 109-18) amended…
On Jun. 9, 2005, the U.S. Food and Drug Administration (FDA) announced it had expanded the approved age…
On Jun 8, 2005, Dr. Andras Nagy at Mount Sinai Hospital announced Canada’s first human embryonic stem cell…
On Jun. 8, 2005, the Oklahoma Medical Research Foundation’s Sir Alexander Fleming scholar program celebrated it’s 50th class…
On May 6, 2005, the National Cancer Institute announced the Community Networks Program (CNP), a 5-year initiative to…
On May 3, 2005, the cellular pertussis vaccine combined with the adult formulation of tetanus and diphtheria (Tdap:…
On May 1, 2005, the Wayne State University Karmanos Cancer Institute announced it had acquired its clinical facilities…
On Apr. 29, 2005, Amylin Pharmaceuticals and Eli Lilly announced the FDA had approved BYETTA(TM) (exenatide) injection as…
On Apr. 27, 2005, results from two large National Cancer Institute sponsored randomized clinical trials showed that patients…
On Apr. 25, 2005, the combination of the targeted agent trastuzumab (Herceptin) and standard chemotherapy cuts the risk…
On Apr. 22, 2005, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had granted licensure to…
On Apr. 12, 2005 marked the 50th anniversary of the announcement that the polio vaccine, developed by Jonas…
On Apr. 12, 2005, the National Cancer Institute (NCI) announced the creation of the cancer Biomedical Informatics Grid…
On Apr. 8, 2005, Moores Cancer Center (MCC) at University of California, San Diego opened its new consolidated…
On Apr. 1, 2005, Sanofi pasteur was awarded a five-year $97 million contract from the U.S. Department of…
On Mar. 31, 2005, Siemens, now Sivantos, launched iScan, the world’s first in-office digital earmold impression scanner. This…